As major employers increasingly scale back or eliminate coverage for GLP-1 weight-loss medications like Wegovy and Zepbound, a significant shift is occurring in how Americans access these treatments. Retail giants including Walmart, Costco, CVS, and Amazon are aggressively positioning themselves to fill this void, launching direct-to-consumer (DTC) programs that bypass traditional insurance-based models. By offering […]